JTEC Corporation (2479.T) designs, manufactures and sells high-precision X-ray mirrors for synchrotron facilities; develops, designs, manufactures and sells automated cell culture systems and automation equipment for regenerative medicine, pharmaceuticals, semiconductors, chemicals, printing, color recognition and image processing applications; provides surface treatment services for various materials; and offers support services related to regenerative medicine. The company operates primarily in Japan from its headquarters and research center in Ibaraki, Osaka, with additional facilities including the Tochigi Production Technology Center in Nasushiobara, Tochigi, targeting manufacturing, medical, biotech and research sectors. Founded on December 21, 1993, as a partnership with Osaka Computer Industries, JTEC went public on the Tokyo Stock Exchange Mothers market in February 2018, transitioned through the First Section in September 2020 and Prime Market in April 2022 before re-listing to the Standard Market in August 2025. Recent developments include a comprehensive partnership agreement with University of Hyogo in July 2025 to advance collaborative research; establishment of a joint research department with Osaka University in July 2023; opening of the Tochigi Production Technology Center in April 2022; acquisition of ESCO Ltd. as a wholly owned subsidiary in May 2021; and multiple government-funded R&D projects, such as high-efficiency iPS cell automation technology adopted by the Ministry of Economy, Trade and Industry in 2020 and high-precision X-ray mirror manufacturing methods in 2021.